Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Paula Wojtowicz"'
Autor:
E Tinkler-Hundal, Fiona Brew, Philip Quirke, Karen G. Spink, Fiona S. Togneri, Paula Wojtowicz, M Taylor, Assa Oumie, Henry M. Wood, Joseph M. Foster
Publikováno v:
BMC Medical Genomics
Background The importance of accurate and affordable mutation calling in fixed pathology samples is becoming increasingly important as we move into the era of personalised medicine. The Affymetrix OncoScan® Array platform is designed to produce acti
Autor:
Brendan O'Sullivan, Sofia Alyas, Philippe Taniere, Nayneeta Deshmukh, Mike Griffiths, Fabiana Ramos Vasques, Paula Wojtowicz, Adam J. Devall, Joseph M. Foster, Dominic J. McMullan, Karen G. Spink, Nicholas D. James, Richard T. Bryan, Maurice P. Zeegers, Douglas G. Ward, Kar Keung Cheng, Fiona S. Togneri, Assa Oumie
Publikováno v:
European Journal of Human Genetics
European Journal of Human Genetics, 24(8). Nature Publishing Group
European Journal of Human Genetics, 24(8). Nature Publishing Group
Urothelial bladder cancers (UBCs) have heterogeneous clinical characteristics that are mirrored in their diverse genomic profiles. Genomic profiling of UBCs has the potential to benefit routine clinical practice by providing prognostic utility above
Autor:
Nicola Trim, Jane Soden, Michael J. Griffiths, Paula Wojtowicz, Laura Ford, Judith Caddick, Charles Craddock, Emma Huxley, Sally Jeffries
Publikováno v:
Blood. 128:3184-3184
Metaphase cytogenetic (MC) analysis in patients with myelodysplastic syndrome (MDS) remains the only essential recommended genetic test in Europe(Malcovati et al, Blood 2013). The chromosome abnormalities identified provide evidence of clonality and
Autor:
Dominic J. McMullan, Eric T. Fung, M Taylor, Phil Quirke, Karen G. Spink, Michael J. Griffiths, Sofia Alyas, Katherine E. Keating, Fiona S. Togneri, E Tinkler-Hundal, Paula Wojtowicz, Jeanette Schmidt, Joseph M. Foster, K Southward, Henry M. Wood, Assa Oumie, Fiona Brew
Publikováno v:
Cancer Research. 75:626-626
Objectives Copy number (CN) and somatic mutation (SM) analysis in tumors is rapidly gaining importance in cancer management as a tool for differential diagnosis, determination of prognosis, and selection of therapeutic. Genome-wide copy number and LO